U-Pump announced on social media that it reached a new milestone in its development of an AI-powered, reusable insulin patch ...

Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education.

Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this ...

SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval.

Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U ...

He takes over for Teri Lawver, who in October announced her plans to retire as CCO of the continuous glucose monitor (CGM) ...

Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

Nanowear announced that it entered into a partnership with Dexcom to ingest glucose data from its latest continuous glucose ...

Of the hundreds of millions of people living with diabetes, most liv. Dexcom wants to make sure they have tools to manage it.

(Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast.

Enable Injections announced today that it received CE mark approval for its EnFuse syringe transfer system for drug delivery.